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Abstract
Background-Few studies have evaluated
the influence of colectomy on anti-
neutrophil cytoplasmic antibody (ANCA)
positivity in ulcerative colitis (UC). In
small series of patients it has been sug-
gested that ANCA positivity in UC might
be predictive for development ofpouchitis
after colectomy.
Aimns-To assess the prevalence ofANCA
in UC patients treated by colectomy and a
Brooke's ileostomy (UC-BI) or ileal pouch
anal anastomosis (UC-IPAA), and the
relation between the presence of ANCA,
the type of surgery, and the presence of
pouchitis.
Subjects-63 UC patients treated by colec-
tomy (32 with UC-BI and 31 with UC-
IPAA), 54 UC, and 24 controls.
Methods-Samples were obtained at least
two years after colectomy. ANCA were
detected by indirect immunofluorescent
assay.
Results-There were no differences
between patients with (36/3%) or without
pouchitis (35O0%) and between patients
with UC (550/), UC-BI (40.6%), and UC-
IPAA (35.40/o). However, ANCA preva-
lence significantly decreases in the whole
group of operated patients (38-0%) com-
pared with non-operated UC (p=0.044).
Conclusions-The prevalence ofANCA in
operated patients was significantly lower
than in non-operated UC, suggesting that
it might be related either to the presence
of inflamed or diseased tissue. ANCA
persistence is not related to the surgical
procedure and it should not be used as a
marker for predicting the development of
pouchitis.
(Gut 1996; 38: 894-898)
Keywords: ulcerative colitis, proctocolectomy, ileal
pouch anal anastomosis, antineutrophil cytoplasmic
antibodies, pouchitis.
Ulcerative colitis (UC) and associated condi-
tions such as primary sclerosing cholangitis are
some of the diseases in which antineutrophil
cytoplasmic antibodies (ANCA) have been
described. 1-3 UC associated ANCA (UC-
ANCA) most commonly show an immuno-
fluorescence perinuclear pattern. Although not
universally accepted,3 cytoplasmic and mixed
ANCA patterns have been described associ-
ated to UC.±8 On the other hand, because the
antigenic specificity of UC-ANCA is
unknown,' 3 9 10 they are referred to as atypical
ANCA or x-ANCA by some authors. 1-3
Few studies have specifically evaluated the
influence of colectomy on ANCA positivity in
UC.4 7 11-4 As well as only dealing with a
small series of patients, none of them includes
a large number of cases with Brooke's
ileostomy, which are the only ones that may be
considered absolutely free of disease. On the
other hand, all these series report a high preva-
lence of ANCA in patients with pouchitis
(80-100%).4 7 11-13 Based on the results of
these studies it has been suggested that ANCA
assessment in UC may be useful in predicting
the development of pouchitis in patients
undergoing IPAA.2
The aims of this study were (a) to assess the
prevalence of ANCA in UC patients treated
with colectomy and either a Brooke's ileostomy
or ileal pouch anal anastomosis, and (b) to
determine the relation between the presence of
ANCA, the type of surgery performed, and the
presence of pouchitis.
Methods
PATIENTS AND CONTROLS
Ulcerative colitis patients treated with colectomy
One hundred and forty eight patients with a
diagnosis of UC have had a colectomy since
1973 in three of four hospitals taking part in
the study. The diagnosis had been established
by the Lennard-Jones clinicopathological
criteria.15 Patients with a history of indetermi-
nate colitis were excluded from the study.
Based on the information available, 92 of 114
patients living in Catalonia (31 895 kM2) could
be contacted by phone and asked to participate
in the study. Sixty three of them agreed to be
included. Thirty two had a Brooke's ileostomy
(UC-BI) (15 male, 17 female; 43 years (range:
23-76)) and 31 had an ileal pouch anal anasto-
mosis (UC-ANCA) (18 male, 13 female; 34
years (range: 24-61)). The technique of IPAA
included mucosectomy of the anorectal stump
in five patients, whereas a staple ileal pouch
anal anastomosis was performed in the remain-
ing cases. In all patients a two loop J reservoir
was made.
Disease controls
Fifty four UC patients who had not had an
operation (35 male, 19 female; 40 years (range:
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TABLE I Clinical characteristics of the ulcerative colitis
patients
Patients
Activity
Inactive 21
Mild 21
Moderate 1 1
Severe 1
Extent
Proctitis 16
Left sided colitis 28
Pancolitis 10
Extraintestinal manifestations 5
Treatment
No treatment 12*
Salicylates 37
Corticosteroids 8
Azathioprine 7
Corticosteroid refractory 13
*First episode. Time elapsed from diagnosis: 4 months (0-25).
19-74)), living in Catalonia, attending the
'Hospital Universitari Germans Trias i Pujol'
were included in the study. The diagnostic
criteria were the same as above.
Healthy controls
Twenty four volunteers, living in the same
geographical area (11 male, 13 female; 43 years
(range: 23-72)) acted as a healthy controls.
CLINICAL ASSESSMENT
In all patients a complete clinical assessment
was performed at the time of blood sampling
for ANCA detection. In non-operated UC
patients this included: activity and extent of
the disease, current treatment, time from
diagnosis, extraintestinal manifestations, and
outcome. The activity of the disease was
assessed by means of the Truelove index.16
Table I shows the clinical characteristics of
the non-operated UC patients. The assess-
ment ofUC patients treated with a colectomy
included: time from diagnosis and surgery,
TABLE I Pouchitis disease activity index (PDAI)1415
Criteria Score
Clinical
Stool frequency:
Usual postoperative stool frequency 0
1-2 Stools/day>postoperative usual 1
3 Or more stools/day>postoperative usual 2
Rectal bleeding:
None or rare 0
Present daily 1
Faecal urgency or abdominal cramps:
None 0
Occasional 1
Usual 2
Fever (temperature >37.8°C:
Absent 0
Present 1
Endoscopic inflammation
Oedema 1
Granularity 1
Friability 1
Loss of vascular pattern 1
Mucous exudate 1
Ulceration 1
Acute histological inflammation
Polymorphonuclear leucocyte infiltration:
Mild 1
Moderate+crypt abscess 2
Severe+crypt abscess 3
Ulceration per low power field (mean):
<25% 1
25-50% 2
>50% 3
extraintestinal manifestations, previous and
current treatment, and postoperative outcome.
Eight patients with UC-BI were previous
UC-IPAA that had failed. The primary reason
for pouch excision was chronic pouchitis resis-
tant to medical treatment in two patients and
fistula and pelvic sepsis in six patients. Four of
the second group also had chronic continuous
pouchitis. None of these patients had indeter-
minate or Crohn's colitis. In UC-IPAA
patients, the degree of pouch inflammation
was assessed by means of the modified
Moskowitz index17 18 (Table II). Pouchitis was
defined as a score equal or greater than 7.
Eleven of 31 UC-IPAA patients fulfilled this
criterion at the time of inclusion.
Previous history of confirmed pouchitis
was also recorded. Four of 11 patients with
pouchitis at the time of inclusion had history of
chronic continuous pouchitis resistant to
medical treatment. Table III shows clinical
data of UC patients treated with a colectomy.
Some UC-IPAA patients were taking more
than one drug. None of the patients included
had primary sclerosing cholangitis.
ANTINEUTROPHIL ANTIBODIES DETECTION
Serum was obtained of all patients and controls.
In operated patients, samples were obtained at
least two years after colectomy. ANCA were
detected using an indirect immunofluorescence
microscopy detection method. Commercially
available slides containing cytospin smears of
human ethanol fixed neutrophils (INOVA
Diagnostic, San Diego, CA) were used as sub-
strate. Diluted serum samples in phosphate
buffered saline (PBS) were incubated on the
slides for 30 minutes. After washing in PBS, the
slides were incubated again for 30 minutes
with fluorescein conjugated rabbit immuno-
globulins to human immunoglobulin G
(DAKO, Copenhagen, Denmark) at a pre-
determined optimal dilution of 1/100 in PBS.
Slides were washed in PBS twice, mounted in
glycerol, and read immediately under fluores-
cence microscopy at 400X (Axioplan, Zeiss,
Germany).
Slides were read by two independent
observers who were unaware of the clinical
diagnosis. Control ANCA positive and nega-
tive sera and PBS were included in each test
batch. A serum was considered positive for
ANCA when a clear perinuclear fluorescence
at a 1:20 dilution was observed or when a
TABLE III Clinical characteristics of the UC patients
treated with a colectomy
UC-IPAA UC-IPAA
UC-BI pouchitis no pouchitis
Years from diagnosis 14 (4-36) 6 (2-34) 7 (2-24)
Years from surgery 9 (2-16) 4 (2-9) 4 (2-9)
Clinical score* - 2 (0-4) 0 (0-3)
Endoscopic score* - 4 (3-6) 0 (0-3)
Histological score* - 2 (1-5) 1 (0-3)
Global score* - 8 (7-11) 3 (1-6)
Treatment (patients):
No treatment 32 3 14
Salicylates 0 2 3
Local corticosteroids 0 3 0
Antibioticst 0 4 5
*Pouchitis disease activity index; tmetronidazole/tetracyclines.
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cytoplasmic staining was observed at a 1:40
dilution. The second cut off dilution was
chosen to eliminate unspecific cytoplasmic
positivity yielded by some negative sera. All
negative sera and those given as positive by
only one observer were retested blindly. Serum
samples given as positive by only one observer
in duplicate assay were considered as negative.
Positive ANCA samples were titrated to a
dilution of 1/1280.
To differentiate positive ANCA from anti-
nuclear antibodies (ANA) that mimic ANCA,
all positive sera were tested with HEp-2 cells
and rat liver sections, which are highly sensitive
for ANA detection. All ANA positive sera with
stronger titres than that observed in neutrophil
slides were considered as ANCA negative.
This occurred in four patients (three non-
operated and one operated) and one healthy
control.
All assays were performed at the Research
Laboratories of the Hospital Universitary
'Germans Trias i Pujol'.
STATISTICAL ANALYSIS
Comparison of the frequencies between
patients with or without pouchitis were
analysed using the two tail x2 and Yates's cor-
rection. The frequencies between UC, UC-IB,
and UC-IPAA were compared using a two tail
X2 and the comparison between operated and
non-operated UC patients was performed
using a left sided Fisher exact test. Titres were
compared using the Kruskal-Wallis test. The
Spearman rank correlation coefficient was used
to determine associations between titres and
the time elapsed from surgery. The results are
expressed by means of median and frequencies
with their range and 95% confidence intervals
(CI), respectively. The statistical procedures
were performed using the programs of the
Biomedical Data Processing, BMDP (BMDP,
Statistical Software, Los Angeles, California,
1986).
The positivity of ANCA was significantly
higher in all groups studied compared with the
healthy control group (p<0 0001).
Relation between ANCA positivity and the
presence ofpouchitis
In patients with UC-IPAA, there were no
differences in ANCA positivity between those
with (36-3% (CI: 109 to 69.2)) or without
pouchitis (35.0% (CI: 15.5 to 59.2))
(p=0.720).
Two of four (CI: 6.7 to 93.2%) patients with
chronic continuous pouchitis and four of eight
UC-IPAA failure (CI: 15.7 to 84.3%) were
ANCA positive.
As the percentage of ANCA positive
patients was the same as those with or without
pouchitis, they were considered together and
compared with both patients treated with a
colectomy and non-operated UC patients to
determine the influence of a Brooke's
ileostomy upon ANCA positivity.
Relation between ANCA positivity and the type
of surgery performed
There were no differences in ANCA positivity
between patients with UC-BI (40-6% (CI:
23.7 to 59.3)) and UC-IPAA (35.4% (CI: 19.2
to 54.6)) and non-operated UC patients (55%
(CI: 41-4 to 69.1)) (p=0 154).
Because there were no significant differences
between both groups of operated patients, they
were considered together (both UC-BI and
UC-IPAA) and compared with UC non-
operated patients to determine if colectomy
decreases ANCA positivity. There was a
significant decrease in ANCA prevalence in
operated patients - 38.0% (CI: 26.1 to 51-2) -
compared with non-operated UC (55%)
(p=0 044).
The Figure shows the titres of ANCA and
UC, UC-BI, and UC-IPAA. There were no
differences in ANCA titres between groups
ETHICAL CONSIDERATIONS
The study was performed in accordance with
the 1975 Declaration of Helsinki ethical guide-
lines and was approved by the Research and
Ethical Committees of the Hospitals.
Results
Table IV shows the number ofANCA positive
patients and controls in the groups studied.
TABLE IV Number and percentage ofANCA positive
patients
Positive Negative
Ulcerative colitis 30 (55.5%)* 24
UC-BI 13 (40 6%)t 19
UC-IPAA with pouchitis 4 (36.3%)A 7
UC-IPAA without pouchitis 7 (35/0%)§ 13
Healthy controls 0 24
UC-BI=total proctocolectomy plus Brookes ileostomy,
UC-IPAA=proctocolectomy plus ileal pouch anal anastomosis.
*26 p-ANCA; 1 c-ANCA; 3 mixed pattern, t11 p-ANCA;
2 mixed pattern, t3 p-ANCA; 1 mixed pattern, §6 p-ANCA;
1 mixed pattern.
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(p=0755). There was also no correlation
between the time elapsed from surgery and the
titres ofANCA (r= - 0098).
Discussion
There is no agreement about those immuno-
fluorescence ANCA patterns that should be
considered associated with UC. Some labora-
tories have considered that all UC-ANCA are
of the perinuclear type,9 19-21 whereas others
also include those less frequent cases showing
either diffuse cytoplasmic or mixed pattern.4-8
We share this second view as, until the specific
antigen(s) are identified, it does not seem
reasonable to exclude any type of ANCA
pattern when an unequivocal immunofluores-
cence staining is found.
One of the aims of this study was to assess if
removal of the colon results in a decline of
ANCA in UC patients and if there is a relation
to the type of surgery performed. The percent-
age ofANCA positivity in our UC non-operated
patients (55%/o) is similar to other reports,6 22 23
and is within the range described in published
reports (40-80%).4-. 19-25 Whether or no circu-
lating ANCA persist long term after colectomy
in UC patients is not well established. Although
most studies have reported the persistence of
ANCA after surgery,47 11-1325 there are some
reports of postoperative ANCA disappear-
ance.14 26 However, most studies include a small
number of patients and none of them includes a
large number of cases with Brooke's ileostomy.
Although there are no data about the time
course of ANCA behaviour after colectomy,
we thought that two years might be a reason-
able period of time for assessing ANCA clear-
ance, assuming that they are related to the
presence of diseased tissue. We have not found
a significant difference in ANCA positivity
between non-operated UC patients, those with
UC-BI, and those with UC-IPAA, showing
that these antibodies persist in the serum in a
high percentage of UC operated patients long
term after colectomy. However, we found a
significant decrease of ANCA positivity when
both groups of operated patients were con-
sidered together (that is, increasing twofold the
number of operated patients). This finding
might disclose the existence of a weak relation
between ANCA positivity and inflammation,
as has been shown in some studies.6 26 In fact,
our non-operated patients showed a non-
significant trend towards a greater percentage
of ANCA positivity in those with active versus
inactive UC (63% v 43%; p=0.13), and in
those with extensive disease versus proctitis
(6/3% v 31%; p=0 07). An alternative explana-
tion would be that ANCA clearance after
colectomy was a very slow process taking
more than two years and a prospective and
paired assessment before and after surgery in
15 UC patients found a significant decrease in
ANCA titres a mean of two years after colec-
tomy.14 In our study, no differences between
groups with respect to ANCA titres, or any
relation between the titres of ANCA and the
time elapsed from surgery were found.
However, as this was not a paired comparison,
interindividual differences in the ability of
antibody production may have prevented the
discovery of such differences.
In this series we found a similar frequency of
ANCA positivity between those patients with
and without pouchitis. In contrast, several
studies have reported a higher prevalence of
ANCA in patients with pouchitis.4 7 11-13
However, most of them include a small
number of patients with pouchitis or it is not
well defined, or both.4 11-13 In this regard, to
distinguish between relapsing and chronic
continuous pouchitis may be relevant. In the
largest reported series, in which all patients
with pouchitis had chronic inflammation
resistant or dependent on medical treatment,
frequency ofANCA positivity was 100%.7 The
authors suggest that the strong relation
between ANCA and pouchitis would be
related to a specific disease pattern (chronic
continuous pouchitis) rather than to the mere
presence of inflammation.7 In the remaining
studies, it is not stated if those patients with
pouchitis had relapsing or chronic continuous
disease. However, a recent study published as
an abstract, showed that those patients without
pouch inflammation at inclusion, but with pre-
vious episodes of pouchitis, had a 33.30/o of
ANCA positivity.12 This figure is similar to the
percentage found in our patients with pouchi-
tis, most of them having relapsing disease. On
the other hand, in our series two of four
chronic resistant pouchitis and four of eight
IPAA failures had positive ANCA.
Taken as a whole, all these data suggest that
ANCA would not predict the development of
relapsing pouchitis, and the strong association
between ANCA positivity and chronic con-
tinuous pouchitis deserves further confirma-
tion. However, even if a 100% association
(sensitivity) could be confirmed, the low speci-
ficity of ANCA for chronic continuous
pouchitis7 will make the use of this marker
doubtful as a predictor of this condition.
Although all these queries could be only
answered by means of a longitudinal study, its
practicability seems to be questionable. Such a
study would be very long lasting, taking into
account that pouchitis may appear as late as 10
years after surgery.27 28 In the case of chronic
continuous pouchitis, an event occurring in
only 5%/o of the total IPAA,28 the great number
of patients to be included would be an addi-
tional difficulty.
In conclusion, ANCA persist in a high pro-
portion of UC patients after colectomy and its
presence is not related to the type of surgery
performed. The lower percentage found in
operated patients suggests that ANCA
positivity might be related to the presence of
either inflamed or diseased tissue. On the other
hand, ANCA positivity in UC should not be
used as a marker for predicting the develop-
ment of pouchitis and, at present, it does not
seem a good parameter for deciding the type of
surgery to be performed in UC patients.
Part of this study has been presented as a poster at the 95th
Annual Meeting of the American Gastroenterological
Association held in San Diego in May 1995, and published as
an abstract in Gastroenterology 1995; 108: A816.
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